AVDL
Avadel Pharmaceuticals
AVDL
AVDL
154 hedge funds and large institutions have $1.35B invested in Avadel Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
15% more capital invested
Capital invested by funds: $1.17B → $1.35B (+$179M)
0.33% less ownership
Funds ownership: 76.68% → 76.35% (-0.33%)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Holders
154
Holding in Top 10
8
Calls
$31.3M
Puts
$10.9M
Top Buyers
| 1 | +$322M | |
| 2 | +$66.6M | |
| 3 | +$51.9M | |
| 4 |
TSC
Two Seas Capital
Rye,
New York
|
+$25.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.5M |
Top Sellers
| 1 | -$149M | |
| 2 | -$25.3M | |
| 3 | -$12.9M | |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$11.6M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$6.48M |